Which of the following is an antipseudomonal antibiotic?
Trisodium phosphonoformate (foscarnet) is a potent antiviral agent for treating herpes simplex infections. It works by affecting which of the following?
Which of the following statements about imipenem is most accurate?
Arthralgia is commonly caused by which antitubercular drug?
Which of the following is NOT used for anaerobic streptococci?
What is the drug of choice for plague?
Combination of amoxycillin with clavulanic acid is active against which of the following organisms except?
Which anti-tuberculosis drug can cause flu-like symptoms as a side effect?
Which of the following drugs is most likely to be effective against multidrug-resistant strains of Mycobacterium tuberculosis, including those resistant to streptomycin?
Acyclovir is used for which of the following viral infections?
Explanation: **Explanation:** **Pseudomonas aeruginosa** is a notorious Gram-negative opportunistic pathogen known for its intrinsic resistance to many antibiotics. Effective treatment requires specific "antipseudomonal" agents. 1. **Why Ciprofloxacin is correct:** Ciprofloxacin is a second-generation **Fluoroquinolone**. It is the most potent oral antipseudomonal drug. It acts by inhibiting DNA gyrase (Topoisomerase II) and Topoisomerase IV, preventing bacterial DNA replication. While most fluoroquinolones have some Gram-negative activity, Ciprofloxacin (along with Levofloxacin) is specifically indicated for *Pseudomonas* infections, including UTIs and malignant otitis externa. 2. **Why the other options are incorrect:** * **Vancomycin:** A glycopeptide antibiotic that acts on cell wall synthesis. It is strictly active against **Gram-positive** bacteria (e.g., MRSA). It has no activity against Gram-negative organisms like *Pseudomonas* due to its large molecular size, which cannot penetrate the outer membrane. * **Cefaclor:** A **second-generation cephalosporin**. While it has improved Gram-negative coverage compared to the first generation, it lacks activity against *Pseudomonas*. Antipseudomonal cephalosporins are primarily the 3rd generation (Ceftazidime) and 4th generation (Cefepime). * **Tetracycline:** A bacteriostatic protein synthesis inhibitor. *Pseudomonas* is intrinsically resistant to tetracyclines due to efficient efflux pumps. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Antipseudomonal drugs:** "**CAMP FIRE**" * **C:** Carbapenems (Imipenem, Meropenem—*not* Ertapenem) * **A:** Aminoglycosides (Amikacin, Gentamicin, Tobramycin) * **M:** Monobactams (Aztreonam) * **P:** Polymyxins (Polymyxin B, Colistin) * **F:** Fluoroquinolones (Ciprofloxacin, Levofloxacin) * **I:** Inhibitors of Beta-lactamase + Penicillin (Piperacillin-Tazobactam, Ticarcillin-Clavulanate) * **RE:** REspiration Cephalosporins (Ceftazidime, Cefepime, Cefoperazone) * **Note:** Ertapenem is the only Carbapenem that does **not** cover *Pseudomonas*.
Explanation: ### Explanation **Foscarnet (Trisodium Phosphonoformate)** is a unique antiviral agent used primarily for CMV retinitis and acyclovir-resistant Herpes Simplex Virus (HSV) infections. **1. Why Option B is Correct:** Foscarnet is a **pyrophosphate analogue**. Unlike acyclovir or ganciclovir, it does **not** require phosphorylation by viral kinases (like thymidine kinase) to become active. It works by directly binding to the pyrophosphate-binding site on the **viral DNA polymerase**. This binding inhibits the cleavage of pyrophosphate from deoxynucleotide triphosphates, thereby halting viral DNA chain elongation. **2. Analysis of Incorrect Options:** * **Option A:** While foscarnet can inhibit RNA polymerase in some viruses, its primary therapeutic action in treating HSV and CMV is the inhibition of DNA polymerase. * **Option C:** Foscarnet does inhibit HIV reverse transcriptase; however, the question specifically asks for its mechanism in treating **Herpes Simplex infections**, where DNA polymerase is the relevant target. * **Option D:** Foscarnet is highly selective for viral enzymes. It inhibits viral DNA polymerase at concentrations **100 times lower** than those required to inhibit host-cellular DNA polymerase, which accounts for its therapeutic index. **3. High-Yield Clinical Pearls for NEET-PG:** * **No Phosphorylation Required:** This makes it the drug of choice for **acyclovir-resistant HSV** and **ganciclovir-resistant CMV** (which often occur due to mutations in viral kinase enzymes). * **Major Side Effect:** **Nephrotoxicity** is the most common dose-limiting toxicity. * **Electrolyte Imbalances:** It frequently causes symptomatic **hypocalcemia** (due to chelation of divalent cations), hypomagnesemia, and hypokalemia. * **Administration:** It must be given intravenously and requires pre-hydration to minimize renal damage.
Explanation: ### Explanation **Correct Answer: D. In renal dysfunction, dosage reduction is necessary to avoid seizures.** **Reasoning:** Imipenem is a carbapenem antibiotic that is primarily excreted by the kidneys. It possesses a known dose-dependent neurotoxicity, specifically lowering the seizure threshold. In patients with renal impairment, the drug accumulates in the plasma, significantly increasing the risk of **seizures** (especially in patients with pre-existing CNS lesions). Therefore, strict dosage adjustment based on creatinine clearance is mandatory [1]. **Analysis of Incorrect Options:** * **A. Narrow spectrum:** Incorrect. Imipenem has one of the **broadest spectra** of any antibiotic, covering Gram-positive, Gram-negative (including *Pseudomonas*), and anaerobic bacteria. * **B. Fixed combination with cilastatin:** While imipenem *is* administered with cilastatin, this statement is less "accurate" as a standalone pharmacological property compared to the clinical safety profile in Option D. *Note: Cilastatin is a dehydropeptidase-I inhibitor that prevents the renal degradation of imipenem and reduces nephrotoxicity.* * **C. Susceptible to beta-lactamases:** Incorrect. Imipenem is highly **resistant** to most traditional beta-lactamases and cephalosporinases. It is only inactivated by specific carbapenemases (e.g., NDM-1). **NEET-PG High-Yield Pearls:** * **The "Cilastatin" Rule:** Imipenem is always given with Cilastatin to prevent its breakdown by **Dehydropeptidase-I** in the renal tubules. Newer carbapenems like **Meropenem** and **Ertapenem** are resistant to this enzyme and do not require cilastatin. * **Seizure Risk:** Among carbapenems, Imipenem has the highest risk of seizures; Meropenem is preferred if CNS infections (like meningitis) are being treated. * **Spectrum:** It is the drug of choice for **ESBL (Extended Spectrum Beta-Lactamase)** producing organisms [2].
Explanation: **Explanation:** **Pyrazinamide** is the correct answer because it is the most common antitubercular drug associated with **hyperuricemia**, which clinically manifests as **arthralgia** (joint pain). **Mechanism:** Pyrazinamide is a prodrug converted into pyrazinoic acid. This metabolite inhibits the renal excretion of uric acid by competing with it at the organic anion transporter (URAT-1) in the proximal convoluted tubules. The resulting elevation in serum uric acid levels often leads to non-gouty polyarthralgia, though it can occasionally trigger acute gouty arthritis. **Analysis of Incorrect Options:** * **Isoniazid (INH):** Primarily known for **Peripheral Neuropathy** (due to Vitamin B6/Pyridoxine deficiency) and hepatotoxicity. It does not typically cause joint pain. * **Rifampicin:** Most famous for causing **orange-colored secretions** (urine, sweat, tears) and a "flu-like syndrome" when taken intermittently. * **Ethambutol:** Its signature side effect is **Retrobulbar Neuritis**, leading to decreased visual acuity and red-green color blindness. While it can also cause hyperuricemia, it does so much less frequently than Pyrazinamide. **High-Yield Clinical Pearls for NEET-PG:** * **Management:** Arthralgia caused by Pyrazinamide is usually managed with NSAIDs; discontinuation of the drug is rarely required unless frank gout develops. * **Hepatotoxicity:** Pyrazinamide is the **most hepatotoxic** drug among the first-line ATT regimen (P > I > R). * **Ethambutol** is the only **bacteriostatic** first-line ATT drug; the rest are bactericidal. * **Mnemonic for Pyrazinamide:** **P**yrazinamide = **P**ain in joints (**P**urines/Uric acid).
Explanation: **Explanation:** The treatment of anaerobic infections depends on the specific organism and its location. **Anaerobic Streptococci** (such as *Peptostreptococcus*) are generally highly sensitive to traditional anti-Gram-positive agents. **1. Why Carbenicillin is the correct answer:** Carbenicillin is an **extended-spectrum carboxypenicillin** primarily developed for its activity against **Gram-negative bacilli**, specifically *Pseudomonas aeruginosa* and *Proteus* species. While it retains some activity against Gram-positive organisms, its potency is significantly lower than that of Penicillin G. It is not a drug of choice for anaerobic Streptococci, and its clinical use has largely been superseded by Piperacillin/Tazobactam. **2. Why the other options are incorrect:** * **Penicillin (Option A):** Penicillin G remains the **drug of choice** for most anaerobic cocci (except *Bacteroides fragilis*). Anaerobic Streptococci are exquisitely sensitive to it. * **Clindamycin (Option B):** This is a classic anti-anaerobic agent. It is highly effective against Gram-positive anaerobes and is often used as an alternative in penicillin-allergic patients. * **Vancomycin (Option D):** As a glycopeptide, Vancomycin is active against almost all Gram-positive organisms, including anaerobic ones like *Peptostreptococcus* and *Clostridium* species. **High-Yield Clinical Pearls for NEET-PG:** * **Above the Diaphragm Anaerobes:** Usually sensitive to Penicillin and Clindamycin (e.g., *Peptostreptococcus*). * **Below the Diaphragm Anaerobes:** Often dominated by *Bacteroides fragilis*, which produces beta-lactamase. The drugs of choice are **Metronidazole**, Carbapenems, or Beta-lactam/Beta-lactamase inhibitor combinations (e.g., Piperacillin-Tazobactam). * **Metronidazole** is unique because it is highly effective against Gram-negative anaerobes but has **limited activity** against certain anaerobic Gram-positive cocci.
Explanation: **Explanation:** Plague is caused by the Gram-negative coccobacillus ***Yersinia pestis***. Historically and clinically, **Tetracyclines** (specifically Doxycycline) are considered the drug of choice for both the treatment and prophylaxis of plague. **Why Tetracyclines are correct:** Tetracyclines are highly effective against *Y. pestis*. **Doxycycline** is preferred due to its superior pharmacokinetic profile (longer half-life and better tissue penetration). While Aminoglycosides (like Streptomycin or Gentamicin) are often used for severe or septicemic cases, Tetracyclines remain the standard recommendation in many guidelines, especially for uncomplicated cases and post-exposure prophylaxis. **Why other options are incorrect:** * **Erythromycin (Option A):** This is a Macrolide. While it has a broad spectrum, it is generally ineffective against *Yersinia pestis* and is not used in the management of plague. * **Ampicillin (Option B):** This is a Penicillin. *Yersinia pestis* often shows resistance to beta-lactams, and clinical outcomes with these drugs are poor. * **Cotrimoxazole (Option D):** While it has some activity and can be used as an alternative in children or pregnant women when other drugs are contraindicated, it is less effective than Tetracyclines or Aminoglycosides. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (Traditional):** Streptomycin (Aminoglycoside) was historically the first choice, but due to toxicity and availability, **Doxycycline** or **Gentamicin** are now preferred. * **Prophylaxis:** Doxycycline is the drug of choice for post-exposure prophylaxis in contacts. * **Safety:** In pregnancy, if plague is suspected, Gentamicin is generally preferred over Tetracyclines due to the risk of fetal bone/teeth abnormalities. * **Alternative:** Fluoroquinolones (like Ciprofloxacin) are also highly effective and FDA-approved for plague.
Explanation: **Explanation:** The combination of **Amoxycillin and Clavulanic acid** (Co-amoxiclav) is a classic example of a beta-lactam paired with a **beta-lactamase inhibitor**. **1. Why MRSA is the correct answer:** The resistance in **MRSA (Methicillin-Resistant Staphylococcus aureus)** is not due to the production of beta-lactamase enzymes, but rather a **structural alteration in the target site**. MRSA possesses an altered Penicillin-Binding Protein (**PBP-2a**), which has a very low affinity for almost all beta-lactam antibiotics. Since Clavulanic acid only inhibits the enzyme (beta-lactamase) and cannot fix the structural defect in the PBP, the combination remains ineffective against MRSA. **2. Analysis of incorrect options:** * **Option B, C, & D:** These organisms (Staph. aureus, N. gonorrhoeae, and E. coli) often develop resistance by producing **beta-lactamase enzymes** (penicillinases) that hydrolyze the beta-lactam ring. Clavulanic acid acts as a "suicide inhibitor," binding irreversibly to these enzymes and protecting Amoxycillin from degradation. This restores the activity of Amoxycillin against these specific resistant strains. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Clavulanic Acid:** It is a suicide inhibitor that inhibits Class A beta-lactamases (e.g., those produced by *S. aureus, H. influenzae, N. gonorrhoeae*). * **MRSA Treatment:** The drug of choice for MRSA is **Vancomycin**. Among beta-lactams, only **5th generation cephalosporins** (Ceftaroline, Ceftobiprole) are active against MRSA. * **Side Effects:** Co-amoxiclav is frequently associated with **diarrhea** (due to clavulanic acid increasing gut motility) and cholestatic jaundice.
Explanation: **Explanation:** **Rifampicin** is the correct answer. The "Flu-like syndrome" is a characteristic adverse effect associated with Rifampicin, typically occurring when the drug is administered **intermittently** (less than twice weekly) or in high doses (more than 600 mg). It is characterized by fever, chills, headache, and malaise, often starting 1–2 hours after the dose. This is believed to be an immunological reaction. **Analysis of Incorrect Options:** * **Isoniazid (INH):** Its hallmark side effects are **Peripheral Neuropathy** (due to Vitamin B6 deficiency) and **Hepatotoxicity**. It does not typically cause a flu-like syndrome. * **Pyrazinamide:** The most common side effects are **Hyperuricemia** (leading to gout) and **Hepatotoxicity** (it is the most hepatotoxic of the first-line drugs). * **Streptomycin:** As an aminoglycoside, its primary toxicities are **Ototoxicity** (specifically vestibulotoxicity) and **Nephrotoxicity**. **High-Yield Clinical Pearls for NEET-PG:** 1. **Rifampicin** is a potent inducer of Cytochrome P450 enzymes (CYP3A4), leading to numerous drug interactions (e.g., failure of oral contraceptives or warfarin). 2. **Orange-red discoloration** of urine, sweat, and tears is a harmless but common side effect of Rifampicin used to monitor patient compliance. 3. Other immunological reactions to Rifampicin include the **"Respiratory syndrome"** (breathlessness), **"Cutaneous syndrome"** (flushing/itching), and **"Abdominal syndrome"** (pain/diarrhea). 4. If flu-like symptoms are severe or accompanied by purpura or hemolysis, the drug must be discontinued immediately.
Explanation: **Explanation:** **Amikacin** is the correct answer because it is a second-line injectable aminoglycoside specifically used in the treatment of **Multidrug-Resistant Tuberculosis (MDR-TB)**. The underlying medical concept is its unique chemical structure; amikacin is a semi-synthetic derivative of kanamycin with a side chain that protects it from most aminoglycoside-modifying enzymes. Consequently, it maintains activity against many mycobacterial strains that have developed resistance to streptomycin and kanamycin. **Analysis of Incorrect Options:** * **Clarithromycin:** While it is a macrolide used for *Mycobacterium avium* complex (MAC), it has no significant clinical efficacy against *M. tuberculosis*. * **Gentamicin:** Although a potent aminoglycoside, it lacks effective *in vivo* activity against *M. tuberculosis* and is not used in TB treatment regimens. * **Spectinomycin:** This aminocyclitol is primarily used as an alternative treatment for gonorrhea. It does not have a role in the treatment of tuberculosis. **Clinical Pearls for NEET-PG:** * **MDR-TB Definition:** Resistance to at least **Isoniazid (INH) and Rifampicin**, the two most potent first-line drugs. * **Aminoglycoside Resistance:** Resistance to streptomycin usually occurs due to mutations in the *rpsL* gene (ribosomal protein S12) or *rrs* gene (16S rRNA). Amikacin often bypasses these mechanisms. * **Adverse Effects:** Like all aminoglycosides, monitor for **ototoxicity** (vestibular/auditory) and **nephrotoxicity**. * **WHO Update:** Recent WHO guidelines prioritize all-oral regimens (e.g., Bedaquiline, Pretomanid, Linezolid), but Amikacin remains a critical "Group C" agent for resistant cases.
Explanation: **Explanation:** **Acyclovir** is a guanosine analogue that acts as a potent antiviral agent specifically targeting the **Herpesviridae** family. Its mechanism of action is highly selective: it requires phosphorylation to acyclovir monophosphate by the viral enzyme **thymidine kinase**. Host cell enzymes then convert it into acyclovir triphosphate, which inhibits viral DNA polymerase and causes DNA chain termination. **Why the correct answer is right:** * **Herpes simplex virus (HSV):** Acyclovir is the drug of choice for HSV-1 and HSV-2 infections (including encephalitis and genital herpes) because these viruses produce the specific thymidine kinase necessary to activate the drug. It is also effective against Varicella-Zoster Virus (VZV). **Why the incorrect options are wrong:** * **Rabies virus:** This is an RNA virus (Rhabdoviridae). Antivirals like acyclovir do not affect its replication; management is strictly via post-exposure prophylaxis (vaccine and immunoglobulin). * **Cytomegalovirus (CMV):** While a herpesvirus, CMV lacks the specific thymidine kinase required to activate acyclovir. **Ganciclovir** is the preferred treatment for CMV as it is activated by a different viral kinase (UL97). * **Human immunodeficiency virus (HIV):** HIV is a retrovirus requiring Reverse Transcriptase inhibitors (like Zidovudine) or Protease inhibitors. Acyclovir has no activity against HIV enzymes. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Resistance:** Most commonly due to the absence or mutation of viral **thymidine kinase**. * **Adverse Effects:** When given IV, it can cause **obstructive nephropathy** (crystalline nephropathy). Ensure adequate hydration. * **Valacyclovir:** A prodrug of acyclovir with better oral bioavailability. * **Drug of Choice:** Acyclovir is the gold standard for **Herpes Simplex Encephalitis**.
Beta-Lactam Antibiotics
Practice Questions
Aminoglycosides
Practice Questions
Macrolides and Ketolides
Practice Questions
Tetracyclines
Practice Questions
Quinolones
Practice Questions
Sulfonamides and Trimethoprim
Practice Questions
Antimycobacterial Drugs
Practice Questions
Antifungal Agents
Practice Questions
Antiviral Drugs
Practice Questions
Antiparasitic Agents
Practice Questions
Principles of Antimicrobial Selection
Practice Questions
Antimicrobial Resistance
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free